Answers are grounded in this paper and cite their sources.
RADIOACTIVE iodine, although an effective form of treatment for hyperthyroidism, has the disadvantage that response of patients to a selected dose varies widely. As yet no method has been devised to select a dose that would be uniformly satisfactory. A quantity that may restore normal thyroid function in one patient may prove entirely ineffective in another, and a similar dose may even induce lasting myxedema in a seemingly comparable case. Myxedema is an undesirable therapeutic result, and, on the other hand, repeated trials with doses that prove inadequate may delay recovery for a year or longer. The current study was . . .
No takes yet. Share an insight, caveat, or question.
Cassidy et al. (1959) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: